多发性骨髓瘤患者血浆细胞因子抑制脂肪干细胞成骨分化
研究探讨多发性骨髓瘤(MM)患者血浆对健康供者脂肪来源间充质干细胞(ASCs)成骨分化的影响。MM血浆抑制HD-ASCs成骨分化,其中7种细胞因子(ANG1、ENA-78、EGF、PDGF-AA/AB/BB、TARC)升高并各自抑制成骨分化;MM-ASCs中CD36和PPARγ上调,MM血浆或7种细胞因子可诱导HD-ASCs表达CD36和PPARγ,提示向脂肪分化偏移。
要点
- MM患者血浆抑制健康ASCs成骨分化。
- 7种细胞因子在MM血浆中升高并各自抑制成骨。
- MM血浆或细胞因子诱导CD36和PPARγ表达。
核心结论
- MM血浆中特定细胞因子(除已知DKK1外)抑制MM-ASCs和HD-ASCs成骨分化,并促向脂肪分化偏移。
研究设计与样本
- 体外研究:用诊断时MM血浆、完全缓解(CR)血浆和健康供者血浆处理健康供者来源ASCs(HD-ASCs),并比较MM-ASCs与HD-ASCs的RNA测序。
主要发现
- MM血浆抑制HD-ASCs成骨分化。
- 7种细胞因子(ANG1、ENA-78、EGF、PDGF-AA/AB/BB、TARC)在MM血浆中升高,各自抑制HD-ASCs成骨分化。
- RNA测序显示MM-ASCs较HD-ASCs上调脂肪分化关键基因CD36和PPARγ。
- MM血浆或7种细胞因子单独处理HD-ASCs可显著增加CD36和PPARγ表达,类似MM-ASCs。
临床怎么用
- 提示MM血浆细胞因子可能通过抑制ASCs成骨分化参与骨病变,为骨病机制提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloma is characterized by bone lesions, which are related to both an increased osteoclast activity and a defect in the differentiation of medullary mesenchymal stem cells (MSCs) into osteoblasts. Outside the medullary environment, adipocyte-derived MSCs (ASCs) could represent a source of functional osteoblasts. However, we recently found a defect in the osteoblastic differentiation of ASCs from myeloma patients (MM-ASCs). We examined the effects of plasma from myeloma patients at diagnosis (MM-plasmas) and in complete remission (CR-plasmas) and from healthy donors on the osteoblastic differentiation of healthy donor-derived ASCs (HD-ASCs). Osteoblastogenesis in HD-ASCs was suppressed by MM-plasmas. Seven cytokines (ANG1, ENA-78, EGF, PDGF-AA/AB/BB, and TARC) were increased in MM-plasmas and separately inhibited the osteoblastic differentiation of HD-ASCs. Comparison of MM-ASCs and HD-ASCs by RNA sequencing showed that two master genes characterizing adipocyte differentiation, CD36 and PPARγ, were upregulated in MM-ASCs as compared to HD-ASCs. Finally, we demonstrated a significant increase in CD36 and PPARγ expression in HD-ASCs in the presence of MM-plasmas or the seven cytokines individually, similarly as in MM-ASCs. We conclude that specific cytokines in MM-plasmas, besides the well-known DKK1, inhibit the osteoblastic differentiation of MM- and HD-ASCs with a skewing towards adipocyte differentiation.
引用
- Kobari L, Auclair M, Piau O, et al. Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells. Leukemia. 2021. PMID: 34556797. doi:10.1038/s41375-021-01428-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。